NeuroAIDS in West Africa: A full circle

Canadian Journal of Neurological Sciences

Volumn 34, Issue 2, 2007, Pages 118-119

  Power, Christopher ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; COGNITIVE DEFECT; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOTOR DYSFUNCTION; PRIORITY JOURNAL; SENSORY NEUROPATHY;

EID: 34347251160     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100005916     Document Type: Editorial

References (18)

1. Power C. Retroviral diseases of the nervous system: pathogenic host response or viral gene-mediated neurovirulence? Trends Neurosc. 2001;24(3):162-9.
2. Mc Arthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005;4(9):543-55.
3. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. Aids. 1999;13(10):1249-53.
4. Ferrando S, van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J. Highly active antiretroviral treatment in HIV infection:benefits for neuropsychological function. AIDS. 1998;12:F65-70.
5. Tozzi V, Balestra P, Galgani S, Narciso P, Ferri F, Sebastiani G, et al. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. Aids. 1999;13(14):1889-97.
6. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology. 2001;56(2):257-60.
7. Price RW, Yiannoutos T, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, et al. Neurological outcomes in late HIV infection:adverse impact of neurological survival and protection effect of antiretroviral therapy. AIDS. 1999;13:1677-85.
8. Letendre SL, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, Heaton RK, et al. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol. 2004;56(3):416-23.
9. Jones G, Power C. Regulation of neural cell survival by HIV-1 infection. Neurobiol Dis. 2006;21(1):1-17.
10. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE. Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol. 2005;64(6):529-36.
11. Selnes OA. Memory loss in persons with HIV/AIDS: assessment and strategies for coping. AIDS. Read 2005;15(6):289-92, 294.
12. Maj M, Satz P, Janssen R, Zaudig M, Starace F, D'Elia L, et al. WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry. 1994;51(1):51-61.
13. Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, et al. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology. 2006;67(2):311-14.
14. Sharp PM, Bailes E, Chaudhuri RR, Rodenburg CM, Santiago MO, Hahn BH. The origins of acquired immune deficiency syndrome viruses: where and when? Philos Trans R Soc Lond B Biol Sci. 2001;356(1410):867-76.
15. Odaise FE, Ogunrun OA, Ogunniyi, AA. Memory performance in HIV/AIDS - a prospective case control study. Can J Neurol Sci. 2007;34(2):154-159.
16. Zeh C, Pieniazek D, Agwale SM, Robbins KE, Odama L, Sani-Gwarzo N, et al. Nigerian HIV type 2 subtype A and B from heterotypic HIV type 1 and HIV type 2 or monotypic HIV type 2 infections. AIDS Res Hum Retroviruses. 2005;21(1):17-27.
17. Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E, et al. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology. 2007;68(5):350-5.
18. Bhigjee AI. Neurological manifestations of HIV infection in Kwazulu-Natal South Africa. J Neurovirol. 2005;11 Suppl 1:17-21.